Two cases are reported of patients who developed a hematologic malignancy several years after intravesical chemotherapy of superficial bladder cancer with etoglucid, doxorubicin, and mitomycin C.
hematologic malignancy
doxorubicin
hematologic malignancy
etoglucid
hematologic malignancy
mitomycin C